Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP532147.RA4E6v0D0dRiMb7S_FV52ty93l6H7jhc2euwB-5DhEut0130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP532147.RA4E6v0D0dRiMb7S_FV52ty93l6H7jhc2euwB-5DhEut0130_assertion type Assertion NP532147.RA4E6v0D0dRiMb7S_FV52ty93l6H7jhc2euwB-5DhEut0130_head.
- NP532147.RA4E6v0D0dRiMb7S_FV52ty93l6H7jhc2euwB-5DhEut0130_assertion description "[Interestingly, HDAC1 association with Sp1 and with the P-Rex1 promoter were much weaker in metastatic prostate cancer PC-3 cells than in non-metastatic prostate cancer cells, and HDAC inhibitors only had very modest stimulatory effects on P-Rex1 promoter activity and P-Rex1 expression in PC-3 cells.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP532147.RA4E6v0D0dRiMb7S_FV52ty93l6H7jhc2euwB-5DhEut0130_provenance.
- NP532147.RA4E6v0D0dRiMb7S_FV52ty93l6H7jhc2euwB-5DhEut0130_assertion evidence source_evidence_literature NP532147.RA4E6v0D0dRiMb7S_FV52ty93l6H7jhc2euwB-5DhEut0130_provenance.
- NP532147.RA4E6v0D0dRiMb7S_FV52ty93l6H7jhc2euwB-5DhEut0130_assertion SIO_000772 21636851 NP532147.RA4E6v0D0dRiMb7S_FV52ty93l6H7jhc2euwB-5DhEut0130_provenance.
- NP532147.RA4E6v0D0dRiMb7S_FV52ty93l6H7jhc2euwB-5DhEut0130_assertion wasDerivedFrom befree-20140225 NP532147.RA4E6v0D0dRiMb7S_FV52ty93l6H7jhc2euwB-5DhEut0130_provenance.
- NP532147.RA4E6v0D0dRiMb7S_FV52ty93l6H7jhc2euwB-5DhEut0130_assertion wasGeneratedBy ECO_0000203 NP532147.RA4E6v0D0dRiMb7S_FV52ty93l6H7jhc2euwB-5DhEut0130_provenance.